Cargando…

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma

Glioblastoma (GBM) patients exhibit high mortality and recurrence rates despite multimodal therapy. Small nucleolar RNA host genes (SNHGs) are a group of long noncoding RNAs that perform a wide range of biological functions. We aimed to reveal the role of SNHGs in GBM subtypes, cell infiltration int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yang, Gao, Zijie, Xu, Jianye, Wang, Huizhi, Guo, Qindong, Xue, Hao, Zhao, Rongrong, Guo, Xing, Li, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493242/ https://www.ncbi.nlm.nih.gov/pubmed/36159816 http://dx.doi.org/10.3389/fimmu.2022.986615

Ejemplares similares

The Non-N(6)-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
por: Xu, Jianye, et al.
Publicado: (2022)

Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022)

The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
por: Zhao, Rongrong, et al.
Publicado: (2021)

A Comprehensive Analysis of METTL1 to Immunity and Stemness in Pan-Cancer
por: Gao, Zijie, et al.
Publicado: (2022)

SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages
por: Fan, Yang, et al.
Publicado: (2023)

Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease
por: Zhao, Songyun, et al.
Publicado: (2023)

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia
por: Guo, Qindong, et al.
Publicado: (2023)

MicroRNA-29a-3p delivery via exosomes derived from engineered human mesenchymal stem cells exerts tumour suppressive effects by inhibiting migration and vasculogenic mimicry in glioma
por: Zhang, Zongpu, et al.
Publicado: (2021)

SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner
por: Zhang, Shouji, et al.
Publicado: (2022)

Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction
por: Xu, Jianye, et al.
Publicado: (2021)

Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells
por: Chen, Zihang, et al.
Publicado: (2021)

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
por: Gao, Zijie, et al.
Publicado: (2022)

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma
por: Sun, Zhongzheng, et al.
Publicado: (2022)

EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3
por: Pan, Ziwen, et al.
Publicado: (2022)

ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells
por: Gao, Zijie, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
por: Guo, Sen, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs
por: Qi, Yanhua, et al.
Publicado: (2022)

Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma
por: Sae-fung, Apiwit, et al.
Publicado: (2023)

Novel exosome-related risk signature as prognostic biomarkers in glioblastoma
por: Ding, Mingyan, et al.
Publicado: (2023)

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis
por: He, Zheng, et al.
Publicado: (2020)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
por: Zhang, Zhao-Cong, et al.
Publicado: (2021)

Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature
por: Chen, Yuxuan, et al.
Publicado: (2022)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
por: Huang, Boyuan, et al.
Publicado: (2023)

γδ T cells as a potential therapeutic agent for glioblastoma
por: Kang, In, et al.
Publicado: (2023)

Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia
por: Yang, You, et al.
Publicado: (2022)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
por: Tong, Shiao, et al.
Publicado: (2022)

The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2
por: Li, Boyan, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related prognostic model for glioblastoma
por: Zhang, Bohong, et al.
Publicado: (2023)

Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2022)

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma
por: Guo, Yangyang, et al.
Publicado: (2023)

Putting Proteomics Into Immunotherapy for Glioblastoma
por: Chen, Liangyu, et al.
Publicado: (2021)

Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Identification and Validation of the Signatures of Infiltrating Immune Cells in the Eutopic Endometrium Endometria of Women With Endometriosis
por: Wu, Xiang-Guang, et al.
Publicado: (2021)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning
por: Ouyang, Guoqing, et al.
Publicado: (2023)

Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma
por: Wang, Zihao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0aknq405uv1alcblfqfocfg725